IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

POLINA DASGUPTA

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical

NPI
1174037477
CMS profile
10638423
Location
MIAMI, FL

General Payments · PY2021–2024

$17,105.31

  • Reported across 168 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$12,454.95

50 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Medical FL All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $7,800.00 2
Travel and Lodging $2,928.23 11
Food and Beverage $1,726.72 37

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $11,183.68 24
Supernus Pharmaceuticals, Inc. $679.49 8
ABBVIE INC. $374.38 9
Otsuka America Pharmaceutical, Inc. $58.48 2
Janssen Pharmaceuticals, Inc $52.31 2
ITI, Inc. $36.99 2
Takeda Pharmaceuticals U.S.A., Inc. $31.03 1
Corium, Inc. $22.23 1
IDORSIA PHARMACEUTICALS US INC $16.36 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,500.00 1
PY2022 $803.27 18
PY2023 $2,347.09 99
PY2024 $12,454.95 50

Payment records · PY2024 (50)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.40 01/02/2024 Food and Beverage Undisputed 01/23/2026 1106987442 CMS
ABBVIE INC. $19.20 01/09/2024 Food and Beverage Undisputed 01/23/2026 1106987444 CMS
ABBVIE INC. $19.96 01/17/2024 Food and Beverage Undisputed 01/23/2026 1106987446 CMS
ABBVIE INC. $19.20 01/26/2024 Food and Beverage Undisputed 01/23/2026 1106987448 CMS
ABBVIE INC. $15.85 02/02/2024 Food and Beverage Undisputed 01/23/2026 1106987450 CMS
ABBVIE INC. $18.00 02/08/2024 Food and Beverage Undisputed 01/23/2026 1106987452 CMS
ABBVIE INC. $18.77 02/28/2024 Food and Beverage Undisputed 01/23/2026 1106987454 CMS
ABBVIE INC. $125.00 03/05/2024 Food and Beverage Undisputed 01/23/2026 1106987456 CMS
ABBVIE INC. $125.00 08/01/2024 Food and Beverage Undisputed 01/23/2026 1106987458 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $509.42 03/13/2024 Travel and Lodging Undisputed 01/23/2026 1117900754 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $578.46 03/22/2024 Travel and Lodging Undisputed 01/23/2026 1117900756 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.91 03/27/2024 Food and Beverage Undisputed 01/23/2026 1117900716 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $34.63 03/27/2024 Food and Beverage Undisputed 01/23/2026 1117900720 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.65 03/27/2024 Food and Beverage Undisputed 01/23/2026 1117900724 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $38.80 03/27/2024 Food and Beverage Undisputed 01/23/2026 1117900730 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $31.10 03/28/2024 Travel and Lodging Undisputed 01/23/2026 1117900718 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $124.65 03/28/2024 Travel and Lodging Undisputed 01/23/2026 1117900736 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $125.75 03/28/2024 Food and Beverage Undisputed 01/23/2026 1117900740 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $361.04 03/28/2024 Travel and Lodging Undisputed 01/23/2026 1117900750 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $143.72 03/29/2024 Travel and Lodging Undisputed 01/23/2026 1117900746 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 05/03/2024 Food and Beverage Undisputed 01/23/2026 1117900726 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 05/03/2024 Travel and Lodging Undisputed 01/23/2026 1117900742 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $3,900.00 05/03/2024 Consulting Fee Undisputed 01/23/2026 1117900758 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $497.44 06/24/2024 Travel and Lodging Undisputed 01/23/2026 1117900752 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.18 06/25/2024 Food and Beverage Undisputed 01/23/2026 1117900714 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.45 06/25/2024 Food and Beverage Undisputed 01/23/2026 1117900722 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $40.50 06/25/2024 Food and Beverage Undisputed 01/23/2026 1117900732 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $43.58 06/25/2024 Food and Beverage Undisputed 01/23/2026 1117900734 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $124.65 07/03/2024 Travel and Lodging Undisputed 01/23/2026 1117900738 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $277.75 07/24/2024 Travel and Lodging Undisputed 01/23/2026 1117900748 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 07/29/2024 Food and Beverage Undisputed 01/23/2026 1117900728 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 07/29/2024 Travel and Lodging Undisputed 01/23/2026 1117900744 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $3,900.00 07/29/2024 Consulting Fee Undisputed 01/23/2026 1117900760 CMS
Corium, LLC $22.23 02/29/2024 Food and Beverage Undisputed 01/23/2026 1100090690 CMS
IDORSIA PHARMACEUTICALS US INC $16.36 02/29/2024 Food and Beverage Undisputed 01/23/2026 1146769605 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.42 01/12/2024 Food and Beverage Undisputed 01/23/2026 1143421148 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.57 02/08/2024 Food and Beverage Undisputed 01/23/2026 1143421151 CMS
Janssen Pharmaceuticals, Inc $22.48 01/18/2024 Food and Beverage Undisputed 01/23/2026 1077968416 CMS
Janssen Pharmaceuticals, Inc $29.83 02/22/2024 Food and Beverage Undisputed 01/23/2026 1077968116 CMS
Otsuka America Pharmaceutical, Inc. $29.24 02/05/2024 Food and Beverage Undisputed 01/23/2026 1119054816 CMS
Otsuka America Pharmaceutical, Inc. $29.24 02/16/2024 Food and Beverage Undisputed 01/23/2026 1119054818 CMS
Supernus Pharmaceuticals, Inc. $84.91 01/16/2024 Food and Beverage Undisputed 01/23/2026 1147840633 CMS
Supernus Pharmaceuticals, Inc. $170.16 01/16/2024 Food and Beverage Undisputed 01/23/2026 1147840641 CMS
Supernus Pharmaceuticals, Inc. $95.96 02/01/2024 Food and Beverage Undisputed 01/23/2026 1147840635 CMS
Supernus Pharmaceuticals, Inc. $163.03 02/08/2024 Food and Beverage Undisputed 01/23/2026 1147840639 CMS
Supernus Pharmaceuticals, Inc. $13.43 02/14/2024 Food and Beverage Undisputed 01/23/2026 1147840631 CMS
Supernus Pharmaceuticals, Inc. $11.52 02/16/2024 Food and Beverage Undisputed 01/23/2026 1147840627 CMS
Supernus Pharmaceuticals, Inc. $12.85 02/20/2024 Food and Beverage Undisputed 01/23/2026 1147840629 CMS
Supernus Pharmaceuticals, Inc. $127.63 08/08/2024 Food and Beverage Undisputed 01/23/2026 1147840637 CMS
Takeda Pharmaceuticals U.S.A., Inc. $31.03 02/20/2024 Food and Beverage Undisputed 01/23/2026 1137731882 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.